Ownership history in UBS Group AG · 30 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in DARIOHEALTH CORP (DRIO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 245 | +106 | +76.3% | 0.00% | $3K | $11.38 |
| 2025 Q3 | REDUCED | 139 | -47,708 | -99.7% | 0.00% | $2K | $17.35 |
| 2025 Q2 | ADDED | 47,847 | +1,870 | +4.1% | 0.00% | $32K | $13.40 |
| 2025 Q1 | ADDED | 45,977 | +40,920 | +809.2% | 0.00% | $28K | $12.24 |
| 2024 Q4 | ADDED | 5,057 | +5,055 | +252750.0% | 0.00% | $4K | $15.72 |
| 2024 Q3 | REDUCED | 2 | -77,308 | -100.0% | 0.00% | $2 | $22.40 |
| 2024 Q2 | ADDED | 77,310 | +71,641 | +1263.7% | 0.00% | $92K | $23.80 |
| 2024 Q1 | ADDED | 5,669 | +3,749 | +195.3% | 0.00% | $9K | $30.60 |
| 2023 Q4 | ADDED | 1,920 | +1,566 | +442.4% | 0.00% | $3K | $34.40 |
| 2023 Q3 | ADDED | 354 | +103 | +41.0% | 0.00% | $1K | $65.60 |
As of 2025 Q4 — sorted by position size